A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
Antimicrobial Agents and Chemotherapy (2020) - Comments
doi: 10.1128/aac.01897-20  issn: 0066-4804  issn: 1098-6596  pubmed: 32958718 

Yohei Doi, Masaya Hibino, Ryota Hase, Michiko Yamamoto, Yu Kasamatsu, Masahiro Hirose, Yoshikazu Mutoh, Yoshito Homma, Masaki Terada, Taku Ogawa, Fumihiro Kashizaki, Toshihiko Yokoyama, Hayato Koba, Hideki Kasahara, Kazuhisa Yokota, Hideaki Kato, Junichi Yoshida, Toshiyuki Kita, Yasuyuki Kato, Tadashi Kamio